Skip to main content

$0.040 -0.002 (-4.76%)

High

$0.04

Low

$0.04

Trades

59

Turnover

$28,759

Volume

696,012
30 June 2023 at 4:10pm
Register to track ACW and receive email alerts.
Subject
ACW Ann: ACW Presentation for BIO International Convention meetings

ACW Ann: ACW announces Phase 2 trial designs for AD & MDD

ACW Ann: Change in substantial holding

ACW Ann: Application for quotation of securities - ACW

ACW Ann: Appendix 3Y - Dr Geoff Brooke

ACW Ann: Appendix 3Y - Dr Steven Gourlay

ACW Ann: Actinogen presentation to Bioshares Biotech Summit 2022

ACW Ann: Actinogen trial results & strategic update presentation

ACW Ann: Actinogen prioritizes Alzheimers Disease & Depression

ACW Ann: Quarterly Activity Report & Appendix 4C

ACW Ann: ACW positive XanaMIA results webcast slide presentation

ACW Ann: ACW announces positive XanaMIA results for Xanamem

ACW Ann: Trading Halt

ACW Ann: Appendix 3Y - Dr Steven Gourlay

ACW Ann: Cleansing Notice

ACW Ann: Application for quotation of securities - ACW

ACW Ann: Results of Meeting

ACW Ann: Letter to Shareholders & Notice of General Meeting

ACW Ann: ACW CEO Presents at European Life Sciences Conference

ACW Ann: Appendix 4D & Half-Year Financial Statements

ACW Ann: Actinogen appoints Prof Paul Rolan as Chief Medical Officer

ACW Ann: Actinogen XanaMIA Part A trial results expected in April

ACW Ann: Actinogen appoints XanaFX Phase 2 trial manager

ACW Ann: Quarterly Activity Report & Appendix 4C

ACW Ann: Application for quotation of securities - ACW

ACW Ann: ACW CEO Presents at San Francisco Healthcare Conference

ACW Ann: Appendix 3Y - Mr Malcolm McComas

ACW Ann: Appendix 3Y - Dr George Morstyn

ACW Ann: Appendix 3Y - Dr Geoff Brooke

ACW Ann: Application for quotation of securities - ACW

ACW Ann: Capital Raising Completion

ACW Ann: New clinical advisory boards

ACW Ann: ACW Strategic Collaboration with Oxford Uni Researchers

ACW Ann: Cleansing Notice

ACW Ann: Application for quotation of securities - ACW

ACW Ann: Offer to Participate in Share Purchase Plan

ACW Ann: Share Purchase Plan Offer Booklet

ACW Ann: Cleansing Notice - Share Purchase Plan

ACW Ann: XanaMIA Part A trial achieves target enrolment

ACW Ann: Cleansing Notice - Share Purchase Plan

ACW Ann: Proposed issue of securities - ACW

ACW Ann: Strategic Update & Capital Raising Investor Presentation

ACW Ann: Program Expansion & Capital Raising

ACW Ann: Trading Halt

ACW Ann: Appendix 3Y - Mr Malcolm McComas

ACW Ann: Appendix 3Y - Dr George Morstyn

ACW Ann: Appendix 3Y - Dr Geoff Brooke

ACW Ann: Application for quotation of securities - ACW

ACW Ann: Results of Annual General Meeting

ACW Ann: AGM Presentations

Register to track ACW and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX